Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
59:31
Anticoagulants in Older Adults
56:26
Navigating the 2024 PAD Guidelines
1:00:58
Updates from the 2023 ASH Meeting
8:07
Current opinions on andexanet alfa
1:00:08
Women’s Health Considerations in Thrombosis Webinar
24:17
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage: The ANNEXA-I Trial
56:54
Perioperative Management of Anticoagulation: Can You Clear My Patient for a Procedure?
1:01:24